Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Ann Thorac Surg ; 56(4): 916-22, 1993 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-8215669

RESUMO

This clinical trial, which was composed of 1,031 adults undergoing cardiac operations, compared the efficacy of a single dose of 1 g of ceftriaxone with a 48-our regimen consisting of flucloxacillin and gentamicin. There was no significant difference (p = 0.89) in the overall incidence of major infections: 30 of 515 patients (5.8%; 95% confidence interval, 5.4% to 6.2%) taking ceftriaxone and 29 of 516 patients (5.6%; 95% confidence interval, 5.2% to 6.0%) taking flucloxacillin and gentamicin. Subgroup analyses, with a lower statistical power, failed to show a significant difference between patients who received ceftriaxone and those who received flucloxacillin/gentamicin: major sternal wound infections arose in 2.7% of the patients taking ceftriaxone versus 1.6% in those on the 48-hour regimen (p = 0.20) and major limb wound infections arose in 4.2% and 5.4%, respectively (p = 0.44). Single-dose prophylaxis was associated with fewer intravenous administrations (864 doses versus 9,570 doses) and cost less (A$17,248 versus A$78,510). Although the regimen that included gentamicin was associated with the greatest biochemical impairment of renal function, the overall toxicity for both groups was low. We conclude that a single dose of ceftriaxone provided cost-efficient prophylaxis for adults undergoing cardiac operations when compared with a 48-hour regimen of gentamicin and flucloxacillin. The general principle revealed by our data is that the short-term administration of an appropriate antibiotic regimen represents optimal prophylaxis for patients undergoing cardiac procedures.


Assuntos
Procedimentos Cirúrgicos Cardíacos , Ceftriaxona/uso terapêutico , Quimioterapia Combinada/uso terapêutico , Pré-Medicação , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Procedimentos Cirúrgicos Cardíacos/economia , Ceftriaxona/administração & dosagem , Análise Custo-Benefício , Quimioterapia Combinada/administração & dosagem , Feminino , Floxacilina/administração & dosagem , Floxacilina/uso terapêutico , Gentamicinas/administração & dosagem , Gentamicinas/uso terapêutico , Humanos , Masculino , Pessoa de Meia-Idade , Pré-Medicação/economia , Infecção da Ferida Cirúrgica/prevenção & controle
2.
Thorax ; 31(2): 121-6, 1976 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-941105

RESUMO

Torulosis is an uncommon, but potentially lethal disease. The aim of this report is to indicate that resection of isolated pulmonary lesions due to torulosis is a safe procedure. Resection has proved useful in the definitive diagnosis and treatment of eight cases seen in this thoracic surgical unit.


Assuntos
Criptococose/cirurgia , Pneumopatias Fúngicas/cirurgia , Adolescente , Adulto , Anfotericina B/efeitos adversos , Anfotericina B/uso terapêutico , Criptococose/diagnóstico , Criptococose/tratamento farmacológico , Feminino , Humanos , Pneumopatias Fúngicas/diagnóstico , Pneumopatias Fúngicas/tratamento farmacológico , Masculino , Meningite/prevenção & controle , Pessoa de Meia-Idade
3.
Aust N Z J Surg ; 45(2): 176-8, 1975 May.
Artigo em Inglês | MEDLINE | ID: mdl-1059405

RESUMO

Since 1968, at the Thoracic Surgery Unit in the Royal Perth Hospital, a combined approach of preoperative deep X-ray therapy and excisional surgery has been adopted for patients with potentially operable carcinoma of the oesophagus. This has produced an improvement in the survival time for middle third lesions when compared with the result previously obtained following unaided surgical excision. The method is described, and the early results are indicated.


Assuntos
Adenocarcinoma/cirurgia , Carcinoma de Células Escamosas/cirurgia , Neoplasias Esofágicas/cirurgia , Adenocarcinoma/mortalidade , Adenocarcinoma/radioterapia , Carcinoma de Células Escamosas/mortalidade , Carcinoma de Células Escamosas/radioterapia , Neoplasias Esofágicas/mortalidade , Neoplasias Esofágicas/radioterapia , Humanos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...